Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

Chronic lymphocytic leukaemia (CLL) is well known to generate impaired immune responses in the host, with the malignant clone residing in well-vascularized tissues and circulating in peripheral blood but also in close proximity to effector cells that are capable, if activated appropriately, of elici...

Full description

Saved in:
Bibliographic Details
Published in:Curr Hematol Malig Rep
Main Authors: Freeman, Ciara L., Gribben, John G.
Format: Artigo
Language:Inglês
Published: Springer US 2016
Subjects:
Chronic Lymphocytic Leukemias (N Jain, Section Editor)
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4796351/
https://ncbi.nlm.nih.gov/pubmed/26857283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-015-0295-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items